首页> Biochemical and biophysical research communications> Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.

导出 LinkOut

翻译打印收藏纠错

第一作者： Dongmin,Shao

第一单位： Section of Vascular Biology, National Heart and Lung Institute, Imperial College London, London, UK.

作者： Dongmin,Shao ^[1] ; Frédéric,Perros ^[2] ; Gaetano,Caramori ^[3] ; Chao,Meng ^[4] ; Peter,Dormuller ^[2] ; Pai-Chien,Chou ^[5] ; Colin,Church ^[6] ; Alberto,Papi ^[3] ; Paolo,Casolari ^[3] ; David,Welsh ^[6] ; Andrew,Peacock ^[6] ; Marc,Humbert ^[2] ; Ian M,Adcock ^[5] ; Stephen J,Wort ^[7]

作者单位： Section of Vascular Biology, National Heart and Lung Institute, Imperial College London, London, UK. ^[1] Faculté de Médecine, Université Paris-Sud, Paris, Clamart, France. ^[2] Dipartimento di Scienze Mediche, Sezione di Medicina Interna e Cardiorespiratoria, Centro Interdipartimentale per lo Studio delle Malattie Infiammatorie delle Vie Aeree e Patologie Fumo-Correlate, University of Ferrara, Ferrara, Italy. ^[3] Section of Vascular Biology, National Heart and Lung Institute, Imperial College London, London, UK; Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. ^[4] Airways Disease, National Heart and Lung Institute, UK. ^[5] Scottish Pulmonary Vascular Unit, University of Glasgow, UK. ^[6] Section of Vascular Biology, National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: s.wort@imperial.ac.uk. ^[7]

关键词 Human endothelial cells IL-33 Nuclear repressor Pulmonary hypertension Soluble ST2